.Pharmacolibrary.Drugs.ATC.N.N07AA01 .Pharmacolibrary.Drugs.ATC.N.N07AA01| name: | Neostigmine | |
| ATC code: | N07AA01 | |
| route: | intravenous | |
| compartments: | 2 | |
| dosage: | 2.5 | mg |
| volume of distribution: | 0.13 | L |
| clearance: | 1.1 | mL/min/kg |
| other parameters in model implementation | ||
Neostigmine is a reversible acetylcholinesterase inhibitor, used primarily in the management of myasthenia gravis, reversal of non-depolarizing neuromuscular blockade after surgery, and treatment of postoperative abdominal distention and urinary retention. It is an approved and widely used medication today.
Pharmacokinetic data reported for adult surgical patients receiving intravenous neostigmine for neuromuscular blockade reversal.
Keating, GM (2016). Sugammadex: A Review of Neuromuscular Blockade Reversal. Drugs 76(10) 1041–1052. DOI:10.1007/s40265-016-0604-1 PUBMED:https://pubmed.ncbi.nlm.nih.gov/27324403
Onrust, SV, & Foster, RH (1999). Rapacuronium bromide: a review of its use in anaesthetic practice. Drugs 58(5) 887–918. DOI:10.2165/00003495-199958050-00011 PUBMED:https://pubmed.ncbi.nlm.nih.gov/10595867